Effects of sustained-release trimetazidine on chronically dysfunctional myocardium of ischemic dilated cardiomyopathy – Six months follow-up result
Background: Ischemic cardiomyopathy is a growing burden in third world countries. So far, benefits of trimetazidine in this group of patients have been suggested by clinical trials mainly conducted in Europe. We evaluated the effect of trimetazidine on ischemic dilated cardiomyopathy in our populati...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2016-11-01
|
| Seri Bilgileri: | Indian Heart Journal |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S001948321600122X |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|